Preferences & Treatment Satisfaction Drivers in Rosacea Patients

• Status: Completed
• Trial end date: 2016-03-10
• Target enrollment: 0
• Participant gender: All

Summary

To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer; LEO Pharma
• Collaborator: Bayer
• Treatments: Azelaic acid; Brimonidine Tartrate; Metronidazole

Criteria

Inclusion Criteria:

• Male or female patients of at least 18 years of age at index date

• At least one prescription for a topical rosacea treatments: Azelaic Acid Gel, Azelaic Acid Cream, Metronidazole Gel, Metronidazole Cream, Metronidazole Emulsion, Metronidazole Lotion, Brimonidine Tartrate Gel

• At least one medical record with a diagnosis code for rosacea (ICD-9: 695.3)

• At least 6 months of data history prior to the index date

• Had at least one encounter at the Reliant Medical Group within 3 months prior to 01 January 2015

Exclusion Criteria:

• None